Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Optimizing triple therapy in patients with metastatic hormone-sensitive prostate cancer.
Borque-Fernando A, Pérez-Fentes DA, Rodrigo-Aliaga M, Puente-Vázquez J, Gómez-Iturriaga A, Unda M, Calleja-Hernández MA, Cózar-Olmo JM, Álvarez-Ossorio JL. Borque-Fernando A, et al. Among authors: rodrigo aliaga m. Actas Urol Esp (Engl Ed). 2024 Dec;48(10):703-717. doi: 10.1016/j.acuroe.2024.10.005. Epub 2024 Oct 30. Actas Urol Esp (Engl Ed). 2024. PMID: 39486794 Review. English, Spanish.
Non-metastatic castration-resistant prostate cancer: management recommendations.
Alcaraz Asensio A, Alvarez Ossorio JL, Cozar Olmo JM, Chantada Abal V, Juarez Soto A, Linares Espinos E, Moreno Jimenez J, Muñoz Rodriguez J, Perez Fentes D, Plata Bello A, Rodrigo Aliaga M, Unda Urzaiz M, Vilaseca A. Alcaraz Asensio A, et al. Among authors: rodrigo aliaga m. Actas Urol Esp (Engl Ed). 2022 May;46(4):193-213. doi: 10.1016/j.acuroe.2021.11.001. Epub 2022 Mar 16. Actas Urol Esp (Engl Ed). 2022. PMID: 35305957 Review. English, Spanish.
Hormone sensitive protocol for metastatic prostate cancer, an update.
Álvarez Ossorio JL, Rodrigo Aliaga M, Rodríguez Antolin A, Unda Urzaiz M, Calleja MÁ, de la Cruz Ruiz M, Blas Quilez J, Hernández Millán IR, Sánchez Zalabardo D, Cozar Olmo JM. Álvarez Ossorio JL, et al. Among authors: rodrigo aliaga m. Actas Urol Esp (Engl Ed). 2023 May;47(4):244-249. doi: 10.1016/j.acuroe.2022.10.002. Epub 2022 Oct 18. Actas Urol Esp (Engl Ed). 2023. PMID: 36270435 English, Spanish.
A multidisciplinary consensus statement on the optimal pharmacological treatment for metastatic hormone-sensitive prostate cancer.
Borque-Fernando A, Calleja-Hernández MA, Cózar-Olmo JM, Gómez-Iturriaga A, Pérez-Fentes DA, Puente-Vázquez J, Rodrigo-Aliaga M, Unda M, Álvarez-Ossorio JL. Borque-Fernando A, et al. Among authors: rodrigo aliaga m. Actas Urol Esp (Engl Ed). 2023 Mar;47(2):111-126. doi: 10.1016/j.acuroe.2022.12.004. Epub 2023 Jan 28. Actas Urol Esp (Engl Ed). 2023. PMID: 36720305 English, Spanish.
Abiraterone in low-volume metastatic hormone-sensitive prostate cancer. Authors' reply.
Borque-Fernando A, Calleja-Hernández MA, Cózar-Olmo JM, Gómez-Iturriaga A, Pérez-Fentes DA, Puente-Vázquez J, Rodrigo-Aliaga M, Unda M, Álvarez-Ossorio JL. Borque-Fernando A, et al. Among authors: rodrigo aliaga m. Actas Urol Esp (Engl Ed). 2023 Jul-Aug;47(6):392-393. doi: 10.1016/j.acuroe.2023.04.014. Epub 2023 Jun 8. Actas Urol Esp (Engl Ed). 2023. PMID: 37301369 English, Spanish. No abstract available.
Clinical and histological predictive factors of reclassification of prostate cancer patients on active surveillance.
Abad Carratalà G, Garau Perelló C, Amaya Barroso B, Sánchez Llopis A, Ponce Blasco P, Barrios Arnau L, Di Capua Sacoto C, Rodrigo Aliaga M. Abad Carratalà G, et al. Among authors: rodrigo aliaga m. Actas Urol Esp (Engl Ed). 2023 Jun;47(5):303-308. doi: 10.1016/j.acuroe.2022.07.003. Epub 2022 Jul 29. Actas Urol Esp (Engl Ed). 2023. PMID: 37272322 English, Spanish.
Role of the 4Kscore test as a predictor of reclassification in prostate cancer active surveillance.
Borque-Fernando Á, Rubio-Briones J, Esteban LM, Dong Y, Calatrava A, Gómez-Ferrer Á, Gómez-Gómez E, Gil Fabra JM, Rodríguez-García N, López González PÁ, García-Rodríguez J, Rodrigo-Aliaga M, Herrera-Imbroda B, Soto-Villalba J, Martínez-Breijo S, Hernández-Cañas V, Soto-Poveda AM, Sánchez-Rodríguez C, Carrillo-George C, Hernández-Martínez YE, Okrongly D. Borque-Fernando Á, et al. Prostate Cancer Prostatic Dis. 2019 Mar;22(1):84-90. doi: 10.1038/s41391-018-0074-5. Epub 2018 Aug 14. Prostate Cancer Prostatic Dis. 2019. PMID: 30108375
Safety of nivolumab in metastatic renal cell carcinoma patients: A real-life experience in a Spanish urology setting.
Amores Bermúdez J, Osman García I, Unda Urzáiz M, Jiménez Marrero P, Ledo Cepero MJ, Llarena R, Flores Martín J, Abad Vivas-Pérez JI, Rodrigo Aliaga M, Juarez Soto A. Amores Bermúdez J, et al. Actas Urol Esp (Engl Ed). 2019 Sep;43(7):364-370. doi: 10.1016/j.acuro.2019.03.005. Epub 2019 May 13. Actas Urol Esp (Engl Ed). 2019. PMID: 31097211 English, Spanish.
Development and implementation of an immunotherapy unit in a urology department.
Rodrigo-Aliaga M, Bosquet-Sanz M, Barrios-Arnau L, Sánchez-Llopis A, Ponce-Blasco P, Monsonís-Usó R, Planelles-Soler P, Garau-Perelló C. Rodrigo-Aliaga M, et al. Actas Urol Esp (Engl Ed). 2023 Jan-Feb;47(1):56-63. doi: 10.1016/j.acuroe.2022.11.006. Epub 2022 Nov 25. Actas Urol Esp (Engl Ed). 2023. PMID: 36442795 Review. English, Spanish.
33 results